BRANDL TALOS advises Sportradar on the acquisition of Vaix

Press release • Corporate Law & Transactions from Stephan Strass, Thomas Talos

BRANDL TALOS advised Sportradar Group (NASDAQ: SRAD), a leading global provider of sports data and content, on its acquisition of Vaix Group, a pioneer in developing Artificial Intelligence (AI) solutions specifically designed for the iGaming industry headquartered in London. The transaction completed on 6 April 2022.

With Vaix’s innovative AI technology, iGaming operators gain a personalized view of their customers, which helps them provide a more targeted, player-friendly experience. Sportradar has already partnered with Vaix for the past two years and incorporated its technology into its Managed Trading Services (MTS) offering, a sophisticated trading, risk, live odds and liability management solution for betting operators.

The BRANDL TALOS deal team consisted of Stephan Strass, Thomas Talos and Céline Dobnikar.

Fladgate LLP (Howard Watt, Alex Haffner, Maddy McAra) advised on aspects of English law. The sell side was advised by Harbottle & Lewis LLP (Anthony Littner, Tom Macleod, Iona Jones).

The team

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 8
            [filter] => raw
        )

)

Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Thomas Talos

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 8
            [filter] => raw
        )

)

Partner / Capital Markets, Corporate Law & Transactions, Gaming & Entertainment

Thomas founded the firm in 2000 together with Ernst Brandl. He is co-publisher of the commentary on the EU Merger Act and (co-)author of numerous publications.

University of Vienna, Faculty of Law (Mag. iur. 1991, Dr. iur. 1994)
University of Virginia, School of Law (LL.M. 1994)

Latest insights into
Corporate Law & Transactions

BRANDL TALOS advised DirectSens on the sale of its market-leading LactoSens® biosensor technology to Kerry Group

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass

Founded in 2013 in Vienna by Christoph Sygmund, Roman Kittl, Roland Ludwig, Wolfgang Harreither and Alfons Felice as a spinoff of BOKU University, DirectSens specializes in developing biosensors, including LactoSens®, a rapid lactose detection tool. The acquisition of LactoSens® by Kerry Group reflects DirectSens' success in developing cutting-edge biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes.

BRANDL TALOS advises Tipico on Sale of U.S. Sportsbook and Online Casino Platform to MGM Resorts International

Press release • Corporate Law & Transactions from Thomas Talos, Stephan Strass, Daniel Habich

Tipico entered into an agreement to sell its U.S. sportsbook and casino platform to LeoVegas group, a subsidiary of MGM Resorts International (NYSE: MGM).

BRANDL TALOS advises Pride Capital Partners on the acquisition of a minority stake in RUBICON alongside RSM Ebner Stolz

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann

Pride Capital Partners, with offices in Amsterdam, Cologne, and Copenhagen, is a hybrid private equity & debt investor focusing on the software and IT industry. With the acquisition of a minority stake in Vienna-based RUBICON Group, Pride completes its first Austrian investment.